Photoinduced inactivation of protein kinase C by dequalinium identifies the RACK-1-binding domain as a recognition site.

The Journal of Biological Chemistry
S A Rotenberg, X G Sun

Abstract

1,1'-Decamethylenebis-4-aminoquinaldinium diiodide (DECA; dequalinium) is an anti-tumor agent and protein kinase C (PKC) inhibitor whose mechanism of action with PKC is unknown. This study reports that with human PKC alpha, DECA exhibited competitive inhibition (Ki = 11.5 +/- 5 microM) with respect to RACK-1 (receptor for activated C kinase-1), an adaptor protein that has been proposed to bind activated PKC following translocation (Ron, D., Luo, J., and Mochly-Rosen, D. (1995) J. Biol. Chem. 270, 24180-24187). When exposed to UV light, DECA covalently modified and irreversibly inhibited PKC (alpha or beta), with IC50 = 7-18 microM. UV/DECA treatment of synthetic peptides modeled after the RACK-1-binding site in the C2 region of PKC beta induced modification of Ser218-Leu-Asn-Pro-Glu-Trp-Asn-Glu-Thr226, but not of a control peptide. This modification occurred at a tryptophan residue (Trp223) that is conserved in all conventional PKC isoforms. In overlay assays with native RACK-1 that had been immobilized on nitrocellulose, UV-treated control PKC alpha bound well to RACK-1, whereas UV/DECA-inactivated PKC alpha had reduced binding activity. The significance of these findings is shown with adenocarcinoma cells, which, when pretrea...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Nov 16, 1992·Biochemical and Biophysical Research Communications·B L Smith, D Mochly-Rosen
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C HeligeH A Tritthart
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·D Mochly-RosenJ Lopez
May 16, 1988·Biochemical and Biophysical Research Communications·S Zhuo, W S Allison
Jan 1, 1988·Annual Review of Cell Biology·L B Chen
Apr 15, 1988·Biochemical Pharmacology·T NakadateP M Blumberg
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M J WeissL B Chen
Dec 1, 1995·The Journal of Biological Chemistry·A C Newton
Oct 13, 1995·The Journal of Biological Chemistry·D RonD Mochly-Rosen
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·D RonD Mochly-Rosen

❮ Previous
Next ❯

Citations

Apr 23, 2009·Assay and Drug Development Technologies·Richard M Eglen, Terry Reisine
Feb 24, 2009·Current Opinion in Cell Biology·Jon RoffeyPeter J Parker
Aug 4, 1998·Structure·H PappaN Q McDonald
Sep 16, 2008·Insect Biochemistry and Molecular Biology·Guo-Xing QuanBasil M Arif
May 5, 2017·Endocrinology·Maniselvan KuppusamyCelso E Gomez-Sanchez
Aug 12, 2014·Nature Communications·Nir FlumanEitan Bibi
Sep 11, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·Joshua M V MammenJeffrey B Matthews
Nov 19, 2002·Molecular Pharmacology·Angela McCahillStephen J Yarwood
Sep 10, 1999·The Journal of Biological Chemistry·D RonA Gordon
Jul 17, 2001·American Journal of Physiology. Heart and Circulatory Physiology·D H KorzickE G Lakatta
Feb 13, 2021·Biochemical Pharmacology·Christian Bailly
Jul 15, 2004·Journal of Cell Science·Hee-Young ParkBarbara A Gilchrest
Oct 9, 2021·Pflügers Archiv : European journal of physiology·Maria A GandiniGerald W Zamponi

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.